市場調查報告書

抗病毒藥物療法的全球市場:新型冠狀病毒感染疾病(COVID-19)的影響與成長

Anti-Viral Drug Therapy Global Market Report 2020-30: Covid 19 Implications and Growth

出版商 The Business Research Company 商品編碼 932434
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
抗病毒藥物療法的全球市場:新型冠狀病毒感染疾病(COVID-19)的影響與成長 Anti-Viral Drug Therapy Global Market Report 2020-30: Covid 19 Implications and Growth
出版日期: 2020年04月16日內容資訊: 英文
簡介

本報告調查了COVID-19病毒對抗病毒藥物療法市場的影響,並提供企業的策略負責人,行銷負責人,上級管理人員有助於評估在治療COVID-19的患者中發揮重要作用之抗病毒藥物療法的需求趨勢所需的必要信息。

本報告提供全球抗病毒藥物療法的市場調查,提供新型冠狀病毒感染疾病(COVID-19)的影響與今後展望,最大的市場與急速增長的市場,闡明整體性定向經濟趨勢和人口動態,與接近市場的關聯性,今後的市場的要素等,以及從2015年∼2019年的趨勢與2019年∼2030年的預測,世界各地區和各國的市場分析,競爭情形主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 抗病毒藥物療法市場特徵

第3章 抗病毒藥物療法的市場規模與成長

  • 2015年∼2019年的市場趨勢
    • 促進市場成長的要素
    • 阻礙市場成長要素
  • 2019年∼2023年,2025年,2030年的市場預測
    • 促進市場成長的要素
    • 阻礙市場成長要素

第4章 抗病毒藥物療法的市場區隔

  • 各藥物類別市場迄今趨勢與今後的預測
    • DNA聚合酵素抑制劑
    • 逆轉錄酵素抑制劑
    • 蛋白分解酵素抑制劑
    • 神經胺糖酸酶抑制劑
    • 其他
  • 各用途市場的迄今趨勢與今後的預測
    • HIV
    • 肝炎
    • 皰疹
    • 流感
    • 其他

第5章 各地區,各國市場分析

  • 各地區市場迄今趨勢與今後的預測
  • 各國市場的迄今趨勢與今後的預測

第6章 亞太地區市場

  • 市場概要
  • 各藥物類別市場迄今趨勢與今後的預測

第7章 中國市場

  • 市場概要
  • 各藥物類別市場迄今趨勢與今後的預測

第8章 印度市場

  • 市場概要
  • 各藥物類別市場迄今趨勢與今後的預測

第9章 日本市場

  • 市場概要
  • 各藥物類別市場迄今趨勢與今後的預測

第10章 澳洲市場

  • 各藥物類別市場迄今趨勢與今後的預測

第11章 印尼市場

  • 各藥物類別市場迄今趨勢與今後的預測

第12章 韓國市場

  • 各藥物類別市場迄今趨勢與今後的預測

第13章 西歐市場

  • 市場概要
  • 各藥物類別市場迄今趨勢與今後的預測

第14章 英國市場

  • 市場概要
  • 各藥物類別市場迄今趨勢與今後的預測

第15章 德國市場

  • 各藥物類別市場迄今趨勢與今後的預測

第16章 法國市場

  • 各藥物類別市場迄今趨勢與今後的預測

第17章 東歐市場

  • 市場概要
  • 各藥物類別市場迄今趨勢與今後的預測

第18章 俄羅斯市場

  • 各藥物類別市場迄今趨勢與今後的預測

第19章 北美市場

  • 市場概要
  • 各藥物類別市場迄今趨勢與今後的預測

第20章 美國市場

  • 市場概要
  • 各藥物類別市場迄今趨勢與今後的預測

第21章 南美市場

  • 市場概要
  • 各藥物類別市場迄今趨勢與今後的預測

第22章 巴西市場

  • 各藥物類別市場迄今趨勢與今後的預測

第23章 中東市場

  • 市場概要
  • 各藥物類別市場迄今趨勢與今後的預測

第24章 非洲市場

  • 市場概要
  • 各藥物類別市場迄今趨勢與今後的預測

第25章 競爭情形和企業簡介

  • 競爭情形
  • 主要企業的簡介
    • AbbVie Inc.
    • Bristol-Myers-Squibb
    • Cipla
    • F. Hoffmann-La Roche Ltd
    • Gilead Sciences Inc

第26章 主要合併和收購

第27章 市場趨勢與策略

第28章 未來展望和未來性分析

第29章 附錄

  • 簡稱
  • 貨幣
目錄

Anti-Viral Drug Therapy Market Market Global Report 2020: Covid 19 Implications and Growth from The Business Research Company covers this critical market and the impact on it from the Covid 19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for anti-viral drugs which play a critical role in the treatment of patients with Covid 19.

Antiviral drugs help cure patients suffering from viral diseases including Covid-19.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the anti-viral drug therapy market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Anti-Viral Drug Therapy Market market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider anti-viral drug therapy market market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The anti-viral drug therapy market market section of the report gives context. It compares the anti-viral drug therapy market market with other segments of the anti-viral drug therapy market market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, anti-viral drug therapy market indicators comparison.

Scope

Markets Covered: 1) By Drug Class: DNA Polymerase Inhibitors; Reverse Transcriptase Inhibitors; Protease Inhibitors; Neuraminidase Inhibitors; Others

2) By Application: HIV; Hepatitis; Herpes; Influenza; Others

Companies Mentioned: AbbVie Inc.; Bristol-Myers-Squibb; Cipla; F. Hoffmann-La Roche Ltd; Gilead Sciences Inc

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Anti-Viral Drug Therapy Market Market Characteristics

3. Anti-Viral Drug Therapy Market Market Size And Growth

  • 3.1. Global Anti-Viral Drug Therapy Market Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Anti-Viral Drug Therapy Market Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Anti-Viral Drug Therapy Market Market Segmentation

  • 4.1. Global Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • DNA Polymerase Inhibitors
    • Reverse Transcriptase Inhibitors
    • Protease Inhibitors
    • Neuraminidase Inhibitors
    • Others
  • 4.2. Global Anti-Viral Drug Therapy Market Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • HIV
    • Hepatitis
    • Herpes
    • Influenza
    • Others

5. Anti-Viral Drug Therapy Market Market Regional And Country Analysis

  • 5.1. Global Anti-Viral Drug Therapy Market Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Anti-Viral Drug Therapy Market Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Anti-Viral Drug Therapy Market Market

  • 6.1. Asia-Pacific Anti-Viral Drug Therapy Market Market Overview
  • 6.2. Asia-Pacific Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Anti-Viral Drug Therapy Market Market

  • 7.1. China Anti-Viral Drug Therapy Market Market Overview
  • 7.2. China Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Anti-Viral Drug Therapy Market Market

  • 8.1. India Anti-Viral Drug Therapy Market Market Overview
  • 8.2. India Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Anti-Viral Drug Therapy Market Market

  • 9.1. Japan Anti-Viral Drug Therapy Market Market Overview
  • 9.2. Japan Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Anti-Viral Drug Therapy Market Market

  • 10.1. Australia Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Anti-Viral Drug Therapy Market Market

  • 11.1. Indonesia Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Anti-Viral Drug Therapy Market Market

  • 12.1. South Korea Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Anti-Viral Drug Therapy Market Market

  • 13.1. Western Europe Anti-Viral Drug Therapy Market Market Overview
  • 13.2. Western Europe Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Anti-Viral Drug Therapy Market Market

  • 14.1. UK Anti-Viral Drug Therapy Market Market Overview
  • 14.2. UK Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Anti-Viral Drug Therapy Market Market

  • 15.1. Germany Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Anti-Viral Drug Therapy Market Market

  • 16.1. France Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Anti-Viral Drug Therapy Market Market

  • 17.1. Eastern Europe Anti-Viral Drug Therapy Market Market Overview
  • 17.2. Eastern Europe Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Anti-Viral Drug Therapy Market Market

  • 18.1. Russia Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Anti-Viral Drug Therapy Market Market

  • 19.1. North America Anti-Viral Drug Therapy Market Market Overview
  • 19.2. North America Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Anti-Viral Drug Therapy Market Market

  • 20.1. USA Anti-Viral Drug Therapy Market Market Overview
  • 20.2. USA Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Anti-Viral Drug Therapy Market Market

  • 21.1. South America Anti-Viral Drug Therapy Market Market Overview
  • 21.2. South America Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Anti-Viral Drug Therapy Market Market

  • 22.1. Brazil Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Anti-Viral Drug Therapy Market Market

  • 23.1. Middle East Anti-Viral Drug Therapy Market Market Overview
  • 23.2. Middle East Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Anti-Viral Drug Therapy Market Market

  • 24.1. Africa Anti-Viral Drug Therapy Market Market Overview
  • 24.2. Africa Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Anti-Viral Drug Therapy Market Market Competitive Landscape And Company Profiles

  • 25.1. Anti-Viral Drug Therapy Market Market Competitive Landscape
  • 25.2. Anti-Viral Drug Therapy Market Market Company Profiles
    • 25.2.1. AbbVie Inc.
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Bristol-Myers-Squibb
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Cipla
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. F. Hoffmann-La Roche Ltd
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Gilead Sciences Inc
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Anti-Viral Drug Therapy Market Market

27. Anti-Viral Drug Therapy Market Market Trends And Strategies

28. Anti-Viral Drug Therapy Market Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer